MedTrace Logo

Long-term Safety and Effectiveness of LASIK-Xtra Compared to Conventional LASIK

NCT06857032 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2025-03-04

No results posted yet for this study

Summary

Laser in situ keratomileusis (LASIK) is a widely used procedure for the correction of myopia and myopic astigmatism. Despite its high effectiveness and the general safety of the procedure, long-term safety and effectiveness remain a key concern in ophthalmology. A promising further development is the combination of LASIK with corneal UV-riboflavin crosslinking, which promises additional stability of the cornea.1 This study aims to evaluate the long-term safety and effectiveness of this combined method in comparison to classic LASIK. By analysing long-term results, the aim is to gain well-founded insights that will help to optimise the decision on the most suitable procedure for correcting myopia and myopic astigmatism and to ensure the best possible clinical results for patients.

Conditions

  • Tomography
  • Corneal Biomechanics
  • Manifest Ref
  • Endothelial Cells
  • IOP
  • Optical Coherence Tomography

Sponsors & Collaborators

  • University Clinic Frankfurt

    lead OTHER

Principal Investigators

  • Thomas Kohnen, Professor and Doctor · University Hospital Frankfurt am Main - Eye clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2024-12-31
Completion
2025-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06857032 on ClinicalTrials.gov